Christina P Rossitto

Ms. Christina P Rossitto


Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2018 in Biomaterials
Verified
Journal Article
Closed access
YKYamini Krishnan
Yamini Krishnan
HRHolly A. Rees
Holly A. Rees
CRChristina P Rossitto
Christina P Rossitto
SKSi-Eun Kim
Si-Eun Kim
HHHan-Hwa K. Hung
Han-Hwa K. Hung
AGAlan Grodzinsky
Alan Grodzinsky

29 August 2018 in mSphere
Verified
Journal Article
Open access
PDF file
CDChristopher D. Dupont
Christopher D. Dupont
ISIngrid L. Scully
Ingrid L. Scully
RZRoss M. Zimnisky
Ross M. Zimnisky
BMBrinda Monian
Brinda Monian
CRChristina P Rossitto
Christina P Rossitto
JLJ. Christopher Love
J. Christopher Love
Staphylococcus aureus causes severe disease in humans for which no licensed vaccine exists. A novel S. aureus vaccine (SA4Ag) is in development, targeting the capsular polysaccharides (CPs) and two virulence-associated surface proteins. Vaccine-elicited antibody responses to CPs are efficacious against serious infection by other encapsulated bacteria. Studies of natural S. aureus infection have also shown a role for TH17 and/or TH1 responses in protection. Single-antigen vaccines, including CPs, have not been effective against S. aureus; a multiantigen vaccine approach is likely required. However, the impact of addition of protein antigens on the immune response to CPs has not been studied. Here, the immune response induced by a bivalent CP conjugate vaccine (to model the established mechanism of action of vaccine-induced protection against Gram-positive pathogens) was compared to the response induced by SA4Ag, which contains both CP conjugates and protein antigens, in cynomolgus macaques. Microengraving, flow cytometry, opsonophagocytic assays, and Luminex technology were used to analyze the B-cell, T-cell, functional antibody, and innate immune responses. Both the bivalent CP vaccine and SA4Ag induced cytokine production from naive cells and antigen-specific memory B-cell and functional antibody responses. Increases in levels of circulating, activated T cells were not apparent following vaccination, nor was a TH17 or TH1 response evident. However, our data are consistent with a vaccine-induced recruitment of T follicular helper (TFH) cells to lymph nodes. Collectively, these data suggest that the response to SA4Ag is primarily mediated by B cells and antibodies that abrogate important S. aureus virulence mechanisms. IMPORTANCEStaphylococcus aureus causes severe disease in humans for which no licensed vaccine exists. A novel vaccine is in development that targets multiple elements of the bacteria since single-component vaccines have not shown efficacy to date. How these multiple components alter the immune response raised by the vaccine is not well studied. We found that the addition of two protein components did not alter substantially the antibody responses raised with respect to function or mobilization of B cells. There was also not a substantial change in the activity of T cells, another part of the adaptive response. This study showed that protection by this vaccine may be mediated primarily by antibody protection.

2 July 2020 in American Journal of Neuroradiology
Verified
Journal Article
Closed access
PDF file
KYK.A. Yaeger
K.A. Yaeger
JFJ.T. Fifi
J.T. Fifi
JLJ. Lara-Reyna
J. Lara-Reyna
CRChristina P Rossitto
Christina P Rossitto
TLT. Ladner
T. Ladner
JMJ. Mocco
J. Mocco
SUMMARY: New York City has become the global epicenter of the coronavirus 2019 (COVID-19) pandemic. Despite a massive shift in health care resources, cerebrovascular disease continues to be a substantial burden. We review the first 10 patients undergoing thrombectomy following a series of governmental and institutional policy changes diverting resources to the care of critically ill patients with COVID-19. Ten patients with emergent large-vessel occlusion underwent thrombectomy between March 23 and April 1, 2020. Five patients tested positive for the COVID-19 virus. Successful reperfusion was achieved in 9 of 10 patients, at a median time of 37 minutes from vascular access. The postprocedural NIHSS score improved by an average of 7.7 points. Of the 5 patients positive for COVID-19, none have experienced a critical respiratory illness. We report the early incidence of COVID-19 positivity in patients with emergent large-vessel occlusion and demonstrate that thrombectomy continues to be an efficacious option, as well as safe for health care providers.

7 March 2023 in Journal of NeuroInterventional Surgery
Verified
Journal Article
Closed access
PDF file
MAMuhammad Ali
Muhammad Ali
CSColton Smith
Colton Smith
VVVikram Vasan
Vikram Vasan
MDMargaret Downes
Margaret Downes
BSBraxton R Schuldt
Braxton R Schuldt
CKChristopher Kellner
Christopher Kellner
Background Minimally invasive evacuation may help ameliorate outcomes after intracerebral hemorrhage (ICH). However, hospital length of stay (LOS) post-evacuation is often long and costly. Objective To examine factors associated with LOS in a large cohort of patients who underwent minimally invasive endoscopic evacuation. Methods Patients presenting to a large health system with spontaneous supratentorial ICH qualified for minimally invasive endoscopic evacuation if they met the following inclusion criteria: age ≥18, premorbid modified Rankin Scale (mRS) score ≤3, hematoma volume ≥15 mL, and presenting National Institutes of Health Stroke Scale (NIHSS) score ≥6. Demographic, clinical, radiographic, and operative characteristics were included in a multivariate logistic regression for hospital and ICU LOS dichotomized into short and prolonged stay at 14 and 7 days, respectively. Results Among 226 patients who underwent minimally invasive endoscopic evacuation, the median intensive care unit and hospital LOS were 8 (4–15) days and 16 (9–27) days, respectively. A greater extent of functional impairment on presentation (OR per NIHSS point 1.10 (95% CI 1.04 to 1.17), P=0.007), concurrent intraventricular hemorrhage (OR=2.46 (1.25 to 4.86), P=0.02), and deep origin (OR=per point 2.42 (1.21 to 4.83), P=0.01) were associated with prolonged hospital LOS. A longer delay from ictus to evacuation (OR per hour 1.02 (1.01 to 1.04), P=0.007) and longer procedure time (OR per hour 1.91 (1.26 to 2.89), P=0.002) were associated with prolonged ICU LOS. Prolonged hospital and ICU LOS were in turn longitudinally associated with a lower rate of discharge to acute rehabilitation (40% vs 70%, P<0.0001) and worse 6-month mRS outcomes (5 (4–6) vs 3 (2–4), P<0.0001). Conclusions We present factors associated with prolonged LOS, which in turn was associated with poor long-term outcomes. Factors associated with LOS may help to inform patient and clinician expectations of recovery, guide protocols for clinical trials, and select suitable populations for minimally invasive endoscopic evacuation.

6 July 2023 in World Neurosurgery
Verified
Journal Article
Closed access
CRChristina P Rossitto
Christina P Rossitto
ADAlex Devarajan
Alex Devarajan
JZJack Y. Zhang
Jack Y. Zhang
RBReilly Benowitz
Reilly Benowitz
GPGabrielle Price
Gabrielle Price
CKChristopher P. Kellner
Christopher P. Kellner

4 May 2023 in World Neurosurgery
Verified
Journal Article
Closed access
CRChristina P Rossitto
Christina P Rossitto
IOIan C. Odland
Ian C. Odland
HOHolly Oemke
Holly Oemke
DCDanna Cruz
Danna Cruz
RKRoshini Kalagara
Roshini Kalagara
CKChristopher P. Kellner
Christopher P. Kellner